GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
09 Apr, 2026 | 11:36am • Source: NSE
As per attachment
09 Apr, 2026 | 10:43am • Source: BSE
As per attachment
08 Apr, 2026 | 11:25pm • Source: BSE
As per attachment
16 Mar, 2026 | 05:58pm • Source: BSE
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 02, 2026
02 Mar, 2026 | 01:14pm • Source: NSE
As per attachment
02 Mar, 2026 | 12:17pm • Source: BSE
As per attachment
02 Mar, 2026 | 12:15pm • Source: BSE
Transcript
16 Feb, 2026 | 04:58pm • Source: BSE
As per attachment
10 Feb, 2026 | 11:30am • Source: BSE
As attached
09 Feb, 2026 | 07:24pm • Source: BSE
Presentation
09 Feb, 2026 | 03:45pm • Source: BSE
Press Release
09 Feb, 2026 | 03:43pm • Source: BSE
Outcome of Meeting
09 Feb, 2026 | 03:31pm • Source: BSE
As per attachment
03 Feb, 2026 | 10:20am • Source: BSE
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
08 Jan, 2026 | 12:20pm • Source: NSE